We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Correct prescription

27 January 2009

The drug company, Wyeth and their bankers wrestled a clever structure that could benefit all parties. The $22.5bn loan employs a lenderfriendly provision to lure banks into the market. But this trick will only work for companies sporting topnotch credit ratings.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)